Clinical Trial Update: Interventional Ablation for Early-stage Lung Cancer

View source ↗

Summary

An update on a clinical trial evaluating interventional ablation for early-stage non-small cell lung cancer, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Guangzhou Institute of Respiratory Disease | Conditions: Lung Cancer (NSCLC), Early Stage Lung Non-Small Cell Carcinoma | Status: ACTIVE_NOT_RECRUITING